These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22410513)

  • 1. Retinopathy of prematurity promising newer modalities of treatment.
    Niranjan HS; Benakappa N; Reddy KB; Nanda S; Kamath MV
    Indian Pediatr; 2012 Feb; 49(2):139-43. PubMed ID: 22410513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediators involved in retinopathy of prematurity and emerging therapeutic targets.
    Mataftsi A; Dimitrakos SA; Adams GG
    Early Hum Dev; 2011 Oct; 87(10):683-90. PubMed ID: 21700404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.
    Hartnett ME
    Clin Perinatol; 2014 Dec; 41(4):925-43. PubMed ID: 25459781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retinopathy of prematurity - therapy. Part 2].
    Prepiaková Z; Tomčíková D; Kostolná B; Gerinec A
    Cesk Slov Oftalmol; 2014 Apr; 70(2):50-4. PubMed ID: 25030312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
    Eldweik L; Mantagos IS
    Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.
    Walz JM; Bemme S; Pielen A; Aisenbrey S; Breuß H; Alex AF; Wagenfeld L; Schiedel S; Krohne TU; Stahl A;
    Acta Ophthalmol; 2016 Dec; 94(8):e744-e752. PubMed ID: 27197876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk.
    Adams GG; Bunce C; Xing W; Butler L; Long V; Reddy A; Dahlmann-Noor AH
    BMJ Open; 2017 Mar; 7(3):e013366. PubMed ID: 28325857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy of prematurity.
    Jordan CO
    Pediatr Clin North Am; 2014 Jun; 61(3):567-77. PubMed ID: 24852153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinopathy of prematurity.
    Chen J; Smith LE
    Angiogenesis; 2007; 10(2):133-40. PubMed ID: 17332988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Update on Retinopathy of Prematurity (ROP).
    Dogra MR; Katoch D; Dogra M
    Indian J Pediatr; 2017 Dec; 84(12):930-936. PubMed ID: 28674824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of retinopathy of prematurity.
    Smith LE
    Semin Neonatol; 2003 Dec; 8(6):469-73. PubMed ID: 15001119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in diagnosis and treatment for Retinopathy of Prematurity.
    Cernichiaro-Espinosa LA; Olguin-Manriquez FJ; Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
    Int Ophthalmol; 2016 Oct; 36(5):751-60. PubMed ID: 26767656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
    Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
    Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register.
    Holmström G; Hellström A; Jakobsson P; Lundgren P; Tornqvist K; Wallin A
    Br J Ophthalmol; 2016 Dec; 100(12):1656-1661. PubMed ID: 26969711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1 and retinopathy of prematurity in the preterm infant.
    Smith LE
    Biol Neonate; 2005; 88(3):237-44. PubMed ID: 16210846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].
    Machalińska A; Modrzejewska M; Dziedziejko V; Kotowski M; Safranow K; Herbowska A; Karczewicz D
    Klin Oczna; 2009; 111(10-12):302-6. PubMed ID: 20169883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Be cautious to treat retinopathy of prematurity with anti-vascular endothelial growth factor pharmacotherapy].
    Liang JH; Cheng Y
    Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):246-249. PubMed ID: 30982286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic approaches in the treatment of retinopathy of prematurity].
    Jandeck C
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.